Day: November 1, 2021

Former Amgen SVP of Global Development and R&D Strategy and Operations Brings Substantial Drug Development Experience to NuCana EDINBURGH, United Kingdom, Nov. 01, 2021 (GLOBE NEWSWIRE) — NuCana plc (Nasdaq: NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer announced the appointment of Elliott M. Levy, M.D. to its Board of Directors. Dr. Levy brings over 20 years of experience at global pharmaceutical companies, including Amgen and Bristol-Myers Squibb, and has a strong track record of leading clinical strategy and development efforts for numerous programs at all stages of development. “We are thrilled to welcome Dr. Levy to our Board of Directors,” said Hugh S. Griffith, NuCana’s Founder and Chief Executive Officer. “He is a recognized and respected...

MIDLAND, Texas, Nov. 01, 2021 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced financial and operating results for the third quarter ended September 30, 2021. THIRD QUARTER 2021 HIGHLIGHTSQ3 2021 average production of 239.8 MBO/d (404.3 MBOE/d) Q3 2021 Permian Basin production of 223.0 MBO/d (374.3 MBOE/d) Q3 2021 cash flow from operating activities of $1,199 million; Operating Cash Flow Before Working Capital Changes (as defined and reconciled below) of $1,131 million Q3 2021 cash capital expenditures of $391 million; Q3 2021 activity-based capital expenditures incurred of approximately $430 million Q3 2021 Free Cash Flow (as defined and reconciled below) of $740 million Closed previously announced full redemption of $432 million remaining aggregate principal amount...

ANN ARBOR, Mich., Nov. 01, 2021 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the presentation of three abstracts at the American Heart Association (AHA) Scientific Sessions 2021 taking place on November 13-15, 2021. AHA Scientific Sessions 2021On Demand  Session Type: Oral Presentation #266Abstract Title: Factors Associated with Enhanced Low-density Lipoprotein Cholesterol Lowering with Bempedoic Acid Among Patients Enrolled in Phase 3 StudiesAuthors: Christie M. Ballantyne, MD; Harold E. Bays, MD; Jeremy Smart, PharmD; Yang Zhang, PhD; Kausik K. Ray, MD, MPhil   Session Type: Oral Presentation #267Abstract Title: Efficacy and Safety of Bempedoic Acid in Patients with Metabolic SyndromeAuthors: Michael D. Shapiro, DO, MCR; Pam R. Taub, MD; Michael J. Louie, MD, MPH, MSc; Lei Lei, PhD; Christie...

— Additional oral presentation details safety and efficacy data from Phase 3 trial of setmelanotide in BBS —— Also presenting new hunger data from SRC1 and SH2B1 cohorts in Phase 2 Basket Trial and new data on utilization of URO®genetic testing program – BOSTON, Nov. 01, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, this week presented the first-ever data on the health-related quality of life (HRQOL) and experience of patients with Bardet-Biedl syndrome (BBS) who were treated in its Phase 3 trial of setmelanotide at The Obesity Society’s ObesityWeek®, a virtual conference that runs from Nov. 1 to 5.    Also at ObesityWeek®, the company shared an oral presentation...

Rogers, Arkansas, Nov. 01, 2021 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc., one of the largest publicly held automotive retailers in the “integrated auto sales and finance” segment of the used car market, today, announced its Holiday Toy Drive, the company’s 13th year to conduct a toy drive during November. Since 2009, Car-Mart has collected thousands of toys for kids at children’s hospitals. This year, Car-Mart’s goal is to collect 25,000 toys for sharing with 25 hospitals in Car-Mart’s 12-state area. [See the list of hospitals below]. In 2020, Car-Mart collected over 11,000 toys for 15 children’s hospitals. “We are excited to conduct our annual toy drive again this year. All of us at Car-Mart will work hard to make this our largest holiday toy drive in our history and to make this season the brightest one yet...

Roanoke, VA, Nov. 01, 2021 (GLOBE NEWSWIRE) — Luna Innovations Incorporated (NASDAQ: LUNA) announced today it will report its third-quarter financial results for the period ended September 30, 2021 after the close of the stock market on Monday, November 15, 2021.  Following the release, at 5 p.m. Eastern, Scott Graeff, President and Chief Executive Officer; Gene Nestro, Chief Financial Officer; Brian Soller, Chief Operating Officer; and James Garrett, Senior Vice President and General Manager of the Luna Labs Division will host a conference call to discuss the third-quarter earnings results. The investor conference call will be available via live webcast on the Luna website at www.lunainc.com under the tab “Investor Relations.” To participate by telephone, the domestic dial-in number is 1.844.578.9643 and the international dial-in...

Jacksonville, Florida, Nov. 01, 2021 (GLOBE NEWSWIRE) — Everything Blockchain, Inc., (OTCMKTS: OBTX), an advanced platform architect, development and services company and software foundry, specializing in blockchain technologies, decentralized processing, and zero trust applications announced today that it has relocated its headquarters to 12574 Flagler Center Blvd, Suite 101, Jacksonville, Florida 32258. The Company’s headquarters has previously been located on the property of Overwatch Partners, Inc., Everything Blockchain’s controlling shareholder. Overwatch Partners has begun demolition of the current structure which Everything Blockchain operated from, in anticipation to begin construction on a $7 million, 25,000 square foot state of the art technology center. Everything Blockchain intends to relocate to this facility upon...

SAN CLEMENTE, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it plans to release its third quarter 2021 financial results before the U.S. markets open on Monday, November 8, 2021. Representatives of CareTrust REIT’s management team will host a conference call to discuss the results and other current matters later the same day. Conference Call CareTrust REIT invites current and prospective investors to listen to the call on Monday, November 8, 2021 at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). The dial-in number is (844) 220-4972 (U.S./Canada) or (317) 973-4053 (International) and the conference ID number is 4158737. To listen to the call online as a webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investors...

GALVESTON, Texas, Nov. 01, 2021 (GLOBE NEWSWIRE) — American National Group, Inc. (NASDAQ: ANAT) and subsidiaries (collectively, the “Company”) announced net income for the third quarter of 2021 of $51.0 million or $1.90 per diluted share, compared to net income of $171.1 million or $6.36 per diluted share for the same period in 2020. Net income for the third quarter of 2021 was $120.1 million lower than net income for the same period in 2020 primarily because gains on equity securities were $119.6 million less in the third quarter of 2021. In addition, an increase in realized investment earnings of $21.9 million during the third quarter of 2021 was offset by a reduction in after-tax adjusted net operating income of $22.4 million. Net gains on equity securities were $0.5 million or $0.02 per diluted share in the third quarter of...

TORONTO, Nov. 01, 2021 (GLOBE NEWSWIRE) — (TSX:BREA) Brompton Funds Limited (“Brompton” or the “Manager”), the manager of Brompton Global Real Assets Dividend ETF (the “Fund”) is pleased to announce that at a special meeting of unitholders (“Unitholders”) held today (the “Meeting”), Unitholders approved an ordinary resolution to change the name of the Fund to “Brompton Sustainable Real Assets Dividend ETF” and amend the investment objectives of the Fund (as described below) (the “Amendments”). The Amendments are subject to regulatory approval and fulfilling certain requirements of the Toronto Stock Exchange and are expected to take effect on or about November 29, 2021. The Manager believes the Amendments will provide the following benefits:(a) Fundamental Investment Objectives: Amending the Fund’s investment objectives to include...